Personalized mRNA Vaccine Shows Promise in Treating Severe Skin Cancer
Preliminary data from an ongoing clinical trial involving approximately 1,100 patients show that an individualized mRNA vaccine combined with a PD1 inhibitor slows tumor growth and reduces the spread of ... Read More